Comparison

LGD-4033 vs LGD-3303

LGD-4033 delivers bulk and strength; LGD-3303 brings dry, hard muscle with zero bloat.

Effectiveness Profile

LGD-4033
LGD-3303

At a Glance

 LGD-4033LGD-3303
TypeSARMSARM
Legal statusResearchResearch
Half-life24–36 hours6–8 hours
Preferred routeOralOral
Dose frequencyonce-dailytwice-daily
Beginner dose5–5 mg5–10 mg
Intermediate dose5–10 mg10–20 mg
Advanced dose10–20 mg20–30 mg
Cycle length6–8 wks6–10 wks
Bioavailability90%
Time to peak2h1.5h
Active duration24h8h
StorageRoom temperature, dry, away from lightRoom temperature, dry, away from light
PCT requiredYesYes
Ancillaries requiredYesYes
Safe for womenNoNo

Verdict

LGD-4033 wins for: adding visible scale weight in a bulk, 1x/day convenience, strong clinical data, and a well-tolerated side effect profile at moderate doses.

LGD-3303 wins for: dry, aesthetic gains with minimal water retention, pronounced muscle hardness and vascularity, lower androgenic spillover, and recomposition when appearance matters most.

Pick A or B?

Pick LGD-4033 if:

  • You want fast, noticeable lean-mass gains (4–8 lbs) and better strength per cycle
  • Prioritize simple 1×/day dosing and easier compliance
  • Running your first or second SARM cycle and want proven safety/tolerability
  • Cutting but willing to accept some water for strength retention
  • Looking for tons of user logs and clear results reports

Pick LGD-3303 if:

  • You want hard, dry, scale-neutral gains with clear muscle definition
  • Cutting, bridging, or recomping and value a sharp, non-watery look
  • Sensitive to estrogenic or androgenic sides, want minimal prostate/skin impact
  • Willing to split dose 2–3× daily for stable levels
  • Stacking with TRT or low-dose AAS for a lean look without bulk